JPH10257893A5 - - Google Patents

Info

Publication number
JPH10257893A5
JPH10257893A5 JP1997066981A JP6698197A JPH10257893A5 JP H10257893 A5 JPH10257893 A5 JP H10257893A5 JP 1997066981 A JP1997066981 A JP 1997066981A JP 6698197 A JP6698197 A JP 6698197A JP H10257893 A5 JPH10257893 A5 JP H10257893A5
Authority
JP
Japan
Prior art keywords
antibody
chain
region
amino acid
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997066981A
Other languages
English (en)
Japanese (ja)
Other versions
JP4550947B2 (ja
JPH10257893A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from JP06698197A external-priority patent/JP4550947B2/ja
Priority to JP06698197A priority Critical patent/JP4550947B2/ja
Priority to DE69824234T priority patent/DE69824234T2/de
Priority to AU59420/98A priority patent/AU751948B2/en
Priority to EP98105047A priority patent/EP0882794B1/en
Priority to AT98105047T priority patent/ATE268382T1/de
Priority to CA002226400A priority patent/CA2226400C/en
Priority to ES98105047T priority patent/ES2219802T3/es
Publication of JPH10257893A publication Critical patent/JPH10257893A/ja
Publication of JPH10257893A5 publication Critical patent/JPH10257893A5/ja
Publication of JP4550947B2 publication Critical patent/JP4550947B2/ja
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP06698197A 1997-03-19 1997-03-19 ガングリオシドｇｍ２に対するヒト型相補性決定領域（ｃｄｒ）移植抗体 Expired - Lifetime JP4550947B2 (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP06698197A JP4550947B2 (ja) 1997-03-19 1997-03-19 ガングリオシドｇｍ２に対するヒト型相補性決定領域（ｃｄｒ）移植抗体
AT98105047T ATE268382T1 (de) 1997-03-19 1998-03-19 MENSCHLICHE-ßCDR-GRAFTEDß-ANTIKÖRPER GEGEN GANGLIOSID GM2
AU59420/98A AU751948B2 (en) 1997-03-19 1998-03-19 Human complementarity determining region (CDR)-grafted antibody to ganglioside GM2
EP98105047A EP0882794B1 (en) 1997-03-19 1998-03-19 Human complementarity determining region (CDR)-grafted antibody to ganglioside gm2
DE69824234T DE69824234T2 (de) 1997-03-19 1998-03-19 Menschliche"CDR-grafted"-Antikörper gegen Gangliosid GM2
CA002226400A CA2226400C (en) 1997-03-19 1998-03-19 Human complementarity determining region (cdr) - grafted antibody to ganglioside gm2
ES98105047T ES2219802T3 (es) 1997-03-19 1998-03-19 Anticuerpo contra el glangliosido gm2, injertado en la zona de determinacion de complementariedad humana (cdr).

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP06698197A JP4550947B2 (ja) 1997-03-19 1997-03-19 ガングリオシドｇｍ２に対するヒト型相補性決定領域（ｃｄｒ）移植抗体

Publications (3)

Publication Number Publication Date
JPH10257893A JPH10257893A (ja) 1998-09-29
JPH10257893A5 true JPH10257893A5 (enExample) 2005-02-24
JP4550947B2 JP4550947B2 (ja) 2010-09-22

Family

ID=13331716

Family Applications (1)

Application Number Title Priority Date Filing Date
JP06698197A Expired - Lifetime JP4550947B2 (ja) 1997-03-19 1997-03-19 ガングリオシドｇｍ２に対するヒト型相補性決定領域（ｃｄｒ）移植抗体

Country Status (7)

Country Link
EP (1) EP0882794B1 (enExample)
JP (1) JP4550947B2 (enExample)
AT (1) ATE268382T1 (enExample)
AU (1) AU751948B2 (enExample)
CA (1) CA2226400C (enExample)
DE (1) DE69824234T2 (enExample)
ES (1) ES2219802T3 (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407734B1 (en) 1994-10-31 2002-06-18 Nec-Mitsubishi Electric Visual Systems Corporation Power supply system capable of reducing power consumption during interruption of an external input signal given to an operating circuit
US7241568B2 (en) 1996-04-03 2007-07-10 Kyowa Hakko Kogyo Co., Ltd. Anti-fibroblast growth factor-8 monoclonal antibody
PT1914244E (pt) 1999-04-09 2013-07-26 Kyowa Hakko Kirin Co Ltd Processo para regular a actividade de moléculas funcionais sob o ponto de vista imunológico
US6693176B1 (en) 1999-07-23 2004-02-17 University Of Massachusetts Antitumor antibodies, proteins, and uses thereof
AU7449200A (en) * 1999-09-30 2001-04-30 Kyowa Hakko Kogyo Co. Ltd. Derivatives of antibody against ganglioside gm2
FR2807767B1 (fr) * 2000-04-12 2005-01-14 Lab Francais Du Fractionnement Anticorps monoclonaux anti-d
AU2016204535C1 (en) * 2000-04-12 2017-02-23 Laboratoire Français Du Fractionnement Et Des Biotechnologies Anti-D monoclonal antibodies
JP2001299349A (ja) * 2000-04-19 2001-10-30 Suntory Ltd 新規組換え型抗体とそのｃｄｒのアミノ酸配列およびそれをコードする遺伝子
WO2002031140A1 (en) * 2000-10-06 2002-04-18 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions
US6946292B2 (en) 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
ES2303859T3 (es) 2001-06-28 2008-09-01 Kyowa Hakko Kogyo Co., Ltd Anticuerpo humanizado contra el factor de crecimiento fibroblastico 8 y fragmento del anticuerpo.
US7935338B2 (en) 2001-12-11 2011-05-03 University Of Massachusetts Antibodies to treat cancer
WO2003057251A1 (fr) * 2001-12-28 2003-07-17 Kyowa Hakko Kogyo Co., Ltd. Remedes contre l'arthrite
JPWO2003084569A1 (ja) 2002-04-09 2005-08-11 協和醗酵工業株式会社 抗体組成物含有医薬
US20040115204A1 (en) 2002-12-11 2004-06-17 Fanger Gary R. Antibodies to treat cancer
US7691810B2 (en) 2003-10-09 2010-04-06 Kyowa Hakko Kirin Co., Ltd Method of producing recombinant antithrombin III composition
JPWO2005035578A1 (ja) * 2003-10-09 2007-11-22 協和醗酵工業株式会社 ガングリオシドｇｍ２に特異的に結合する抗体組成物
EP2107115A1 (en) 2007-01-24 2009-10-07 Kyowa Hakko Kirin Co., Ltd. Genetically recombinant antibody composition capable of binding specifically to ganglioside gm2
FR2953841B1 (fr) * 2009-12-16 2011-12-30 Centre Nat Rech Scient Anticorps diriges contre le recepteur de la transferrine et leurs utilisations pour l'immunotherapie des tumeurs qui dependent du fer
KR101913440B1 (ko) 2010-03-02 2018-10-30 교와 핫꼬 기린 가부시키가이샤 개변 항체 조성물
KR20150090107A (ko) 2012-12-06 2015-08-05 도쿠리츠다이가쿠호징 가나자와다이가쿠 중피종의 치료 방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69333524T2 (de) * 1992-09-07 2005-06-16 Kyowa Hakko Kogyo Co., Ltd. Humanisierte Antikörper, die mit dem GM2-Gangliosid reagieren

Similar Documents

Publication Publication Date Title
JPH10257893A5 (enExample)
Daugherty et al. Polymerase chain reaction facilitates the cloning, CDRgrafting, and rapid expression of a murine monoclonal antibody directed against the CD18 component of leukocyte integrins
KR100239607B1 (ko) 인화 항체 및 이것의 사용 방법
JP3525221B2 (ja) 免疫抑制剤
JPH10114795A (ja) Ｔｎｆ結合タンパク質
WO2000058480A1 (en) Novel cytidine deaminase
JP3255699B2 (ja) ヒトＩＬ−２レセプターγ鎖分子
JP4550947B2 (ja) ガングリオシドｇｍ２に対するヒト型相補性決定領域（ｃｄｒ）移植抗体
CN112521501A (zh) Gipr抗体及其与glp-1的融合蛋白质，以及其药物组合物和应用
KR100277769B1 (ko) 항-파스 재조합 항체 및 이에 대한 디엔에이
JP3614183B2 (ja) ヒトインターロイキン−６に対する再構成ヒト抗体
CN114057878A (zh) 降低单克隆抗体生产中宿主细胞蛋白含量的亲和纯化方法
JP3231262B2 (ja) ヒトＴｈ１特異的タンパク質及びこれをコードする遺伝子、並びにこれに関連する形質転換体、組換えベクター及び抗体
JP2001500013A (ja) ＨＴ▲下ｍ４▼、治療およびアッセイ方法、アゴニストおよびアンタゴニスト
JP3024311B2 (ja) Ｉｌ−２受容体重鎖に結合するポリペプチド
WO2023225197A2 (en) Klrb1 binding agents and methods of use thereof
JP2009526535A (ja) 新規ｃｃケモカインアンタゴニスト
CA2497937A1 (en) Nuclear factor of activated t cells receptor
JP4059404B2 (ja) 甲状腺機能を刺激する活性を持つ抗体
WO2003057252A1 (en) Human mast cell-expressed membrane proteins
WO1997031110A1 (fr) Molecule de la famille des genes de transfert f, polynucleotide codant pour cette molecule et anticorps actif contre cette molecule
JPH10324699A (ja) 抗ヒトＦａｓヒト化抗体
WO2026017189A2 (zh) 抗il-31抗体、其药物组合物及用途
JP2009513124A (ja) 新規ｃｘｃケモカインアンタゴニスト
JP3844519B2 (ja) 免疫抑制剤